Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression

NCT06004115 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

165

Enrollment

OTHER

Sponsor class

Conditions

Depression, Anxiety
Fear
Depression
Anxiety and Fear
Anxiety Disorders
Anxious Depression

Interventions

DRUG: Lorazepam
OTHER: Placebo

Sponsor

Laureate Institute for Brain Research, Inc.

Collaborators

[object Object]
[object Object]